TI  - Neoadjuvant Pertuzumab in Breast Cancer and Associated Prognostic Factors
AU  - Can, O.
AU  - Ay, S.
AU  - Atci, M.M.
SO  - European Archives of Medical Research 2026;42:156-161.
DO  - 10.14744/eamr.2025.35682